With New Scrutiny, Life Sci Startups Become Risky Targets
In a recent article, Law360 interviewed top federal health care prosecutors who identified an emerging enforcement trend: focusing on startups and other smaller life sciences companies. If this proves to be...To view the full article, register now.
Already a subscriber? Click here to view full article